US › Healthcare

Alpha Teknova Inc (TKNO)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.08-6.84%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$12.2M

Revenue YoY

+18.5%

Net profit

$-3.2M

EPS

$-0.06

EPS estimate

$-0.08

Net margin

-26.0%

EPS came in at -0.06 against a street estimate of -0.08 — a beat of 25.0%.

Key statistics

Market cap

$441.3M

Forward P/E

0.0

P/B

7.66

Book value

$1.17

EPS (TTM)

$-0.31

52-week high

$9.48

52-week low

$1.91

50-day MA

$7.58

200-day MA

$4.66

Beta

0.86

Analyst view

Analysts rate Alpha Teknova Inc a strong buy (7 buy, 1 hold, 0 sell out of 8) with an average price target of $9.67.

Shareholding

Insiders

9.31%

Institutions

87.35%

Largest institutional holders

Fund	Stake
Royce & Associates, LP	3.09%
Vanguard Capital Management, LLC	3.01%
Roubaix Capital, LLC	2.94%
BlackRock Inc	1.64%
UBS Group AG	1.18%
Conestoga Capital Advisors, LLC	0.59%
Geode Capital Management, LLC	0.58%
Bank of America Corp	0.48%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alpha Teknova Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.